These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6314170)

  • 1. Brain noradrenaline and anaesthesia: further characterization of the beta-receptor.
    Mason ST; Angel A
    Neuropharmacology; 1983 Sep; 22(9):1065-9. PubMed ID: 6314170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaesthesia: the role of adrenergic mechanisms.
    Mason ST; Angel A
    Eur J Pharmacol; 1983 Jul; 91(1):29-39. PubMed ID: 6137392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.
    Mason ST; Angel A
    Psychopharmacology (Berl); 1983; 81(1):73-7. PubMed ID: 6415734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain noradrenaline and anaesthesia: behavioural and electrophysiological evidence.
    Mason ST; King RA; Banks P; Angel A
    Neuroscience; 1983 Sep; 10(1):177-85. PubMed ID: 6417556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexinergic neurons and barbiturate anesthesia.
    Kushikata T; Hirota K; Yoshida H; Kudo M; Lambert DG; Smart D; Jerman JC; Matsuki A
    Neuroscience; 2003; 121(4):855-63. PubMed ID: 14580935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective increases in the density of cerebellar beta-1-adrenergic receptors.
    Wolfe BB; Minneman KP; Molinoff PB
    Brain Res; 1982 Feb; 234(2):474-9. PubMed ID: 6277437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
    McNamee EN; Ryan KM; Griffin EW; González-Reyes RE; Ryan KJ; Harkin A; Connor TJ
    Brain Behav Immun; 2010 May; 24(4):660-71. PubMed ID: 20193756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral consequences of activation of beta adrenergic receptors by clenbuterol: evidence for mediation by the central nervous system.
    O'Donnell JM
    Brain Res Bull; 1988 Sep; 21(3):491-7. PubMed ID: 2850845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex.
    McNamee EN; Griffin EW; Ryan KM; Ryan KJ; Heffernan S; Harkin A; Connor TJ
    Neuropharmacology; 2010; 59(1-2):37-48. PubMed ID: 20361987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of beta-adrenoceptors inhibits lordosis behavior in the female rat.
    Mendelson SD; Gorzalka BB
    Pharmacol Biochem Behav; 1988 Apr; 29(4):717-23. PubMed ID: 2842808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological function of descending noradrenaline projections to the spinal cord: role in post-decapitation convulsions.
    Mason ST; Fibiger HC
    Eur J Pharmacol; 1979 Jul; 57(1):29-34. PubMed ID: 477739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
    Hjorth S; Carlsson A
    Eur J Pharmacol; 1986 Sep; 129(1-2):131-8. PubMed ID: 2429847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
    Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 Apr; 136(3):429-32. PubMed ID: 3111866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenaline- and time-dependent changes in neocortical alpha 2- and beta 1-adrenoceptor binding in dorsal noradrenergic bundle-lesioned rats.
    Dooley DJ; Jones GH; Robbins TW
    Brain Res; 1987 Sep; 420(1):152-6. PubMed ID: 2823971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clenbuterol increases norepinephrine release from rat brain slices by a calcium- and receptor-independent mechanism.
    Murugaiah KD; O'Donnell JM
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):311-24. PubMed ID: 7712107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.
    Mason ST; Angel A
    Psychopharmacology (Berl); 1984; 84(3):304-9. PubMed ID: 6440174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses.
    Sporn JR; Wolfe BB; Harden TK; Molinoff PB
    Mol Pharmacol; 1977 Nov; 13(6):1170-80. PubMed ID: 201833
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticotropin-releasing factor reverses the effect of pentobarbital through a beta-noradrenergic mechanism in rats.
    Imaki T; Shibasaki T; Masuda A; Imaki J; Demura H; Shizume K; Ling N
    Life Sci; 1988; 43(10):813-20. PubMed ID: 2842561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of noradrenaline release by presynaptic alpha-2 and beta adrenoceptors in rat atria. Effect of pretreatment with clenbuterol.
    Kazanietz MG; Enero MA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):274-8. PubMed ID: 2554153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased beta I-adrenoceptor density after 6-hydroxydopamine pretreatment in rat colon and lung.
    Ek B; Lundgren B
    Acta Physiol Scand; 1986 Aug; 127(4):455-60. PubMed ID: 3019086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.